This has led to recommendations from multiple studies, including the American Society of Breast Surgeons, for broader genetic testing, encompassing BRCA1/2, PALB2, and other appropriate genes based on the clinical picture, for all patients with a history of breast cancer [42]. Here, PALB2 is linked to breast carcinoma.